This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreozzi, F.
Right arrow Articles by Sesti, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreozzi, F.
Right arrow Articles by Sesti, G.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, March 2007, p. 2372-2383, Vol. 27, No. 6
0270-7306/07/$08.00+0     doi:10.1128/MCB.01340-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Interleukin-6 Impairs the Insulin Signaling Pathway, Promoting Production of Nitric Oxide in Human Umbilical Vein Endothelial Cells{triangledown}

Francesco Andreozzi,1 Emanuela Laratta,1 Cristina Procopio,1 Marta Letizia Hribal,1 Angela Sciacqua,1 Maria Perticone,1 Claudia Miele,2 Francesco Perticone,1 and Giorgio Sesti1*

Department of Clinical and Experimental Medicine, University Magna Græcia of Catanzaro, Catanzaro, Italy,1 Istituto di Endocrinologia ed Oncologia Sperimentale-CNR, Naples, Italy2

Received 21 July 2006/ Returned for modification 12 October 2006/ Accepted 2 January 2007

Interleukin 6 (IL-6) is an independent predictor of type 2 diabetes and cardiovascular disease and is correlated with insulin resistance. Insulin stimulates nitric oxide (NO) production through the IRS-1/PI3-kinase/Akt/eNOS pathway (where IRS-1 is insulin receptor substrate 1, PI3-kinase is phosphatidylinositol 3-kinase, and eNOS is endothelial NO synthase). We asked if IL-6 affects insulin vasodilator action both in human umbilical vein endothelial cells (HUVEC) and in the aortas of C57BL/6J mice and whether this inhibitory effect was caused by increased Ser phosphorylation of IRS-1. We observed that IL-6 increased IRS-1 phosphorylation at Ser312 and Ser616; these effects were paralleled by increased Jun N-terminal protein kinase (JNK) and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation and reversed by JNK and ERK1/2 inhibition. In addition, IL-6 treatment resulted in impaired IRS-1 phosphorylation at Tyr612, a site essential for engaging PI3-kinase. Furthermore, IL-6 treatment reduced insulin-stimulated phosphorylation of eNOS at the stimulatory Ser1177 site and impaired insulin-stimulated eNOS dephosphorylation at the inhibitory Thr495 site. Insulin-stimulated eNOS activation and NO production were also inhibited by IL-6; these effects were reversed by inhibition of JNK and ERK1/2. Treatment of C57BL/6J mice with IL-6 resulted in impaired insulin-dependent activation of the Akt/eNOS pathway in the aorta as a result of JNK and ERK1/2 activation. Our data suggest that IL-6 impairs the vasodilator effects of insulin that are mediated by the IRS-1/PI3-kinase/Akt/eNOS pathway through activation of JNK and ERK1/2.

* Corresponding author. Mailing address: Dipartimento di Medicina Sperimentale e Clinica, Via Tommaso Campanella, 115, 88100 Catanzaro, Italy. Phone: 39-0961-712411. Fax: 39-0961-772626. E-mail: sesti{at}unicz.it.

{triangledown} Published ahead of print on 22 January 2007.

Molecular and Cellular Biology, March 2007, p. 2372-2383, Vol. 27, No. 6
0270-7306/07/$08.00+0     doi:10.1128/MCB.01340-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Procopio, C., Andreozzi, F., Laratta, E., Cassese, A., Beguinot, F., Arturi, F., Hribal, M. L., Perticone, F., Sesti, G. (2009). Leptin-Stimulated Endothelial Nitric-Oxide Synthase via an Adenosine 5'-Monophosphate-Activated Protein Kinase/Akt Signaling Pathway Is Attenuated by Interaction with C-Reactive Protein. Endocrinology 150: 3584-3593 [Abstract] [Full Text]  
  • Kolliputi, N., Waxman, A. B. (2009). IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L6-L16 [Abstract] [Full Text]  
  • Yuen, D. Y.C., Dwyer, R. M., Matthews, V. B., Zhang, L., Drew, B. G., Neill, B., Kingwell, B. A., Clark, M. G., Rattigan, S., Febbraio, M. A. (2009). Interleukin-6 Attenuates Insulin-Mediated Increases in Endothelial Cell Signaling but Augments Skeletal Muscle Insulin Action via Differential Effects on Tumor Necrosis Factor-{alpha} Expression. Diabetes 58: 1086-1095 [Abstract] [Full Text]  
  • Sultan, A., Strodthoff, D., Robertson, A.-K., Paulsson-Berne, G., Fauconnier, J., Parini, P., Ryden, M., Thierry-Mieg, N., Johansson, M. E., Chibalin, A. V., Zierath, J. R., Arner, P., Hansson, G. K. (2009). T Cell-Mediated Inflammation in Adipose Tissue Does Not Cause Insulin Resistance in Hyperlipidemic Mice. Circ. Res. 104: 961-968 [Abstract] [Full Text]  
  • LeBlanc, A. J., Shipley, R. D., Kang, L. S., Muller-Delp, J. M. (2008). Age impairs Flk-1 signaling and NO-mediated vasodilation in coronary arterioles. Am. J. Physiol. Heart Circ. Physiol. 295: H2280-H2288 [Abstract] [Full Text]  
  • Anderson, N., Borlak, J. (2008). Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacol. Rev. 60: 311-357 [Abstract] [Full Text]  
  • Bobik, A. (2008). Apolipoprotein CIII and Atherosclerosis: Beyond Effects on Lipid Metabolism. Circulation 118: 702-704 [Full Text]  
  • Kawakami, A., Osaka, M., Tani, M., Azuma, H., Sacks, F. M., Shimokado, K., Yoshida, M. (2008). Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction. Circulation 118: 731-742 [Abstract] [Full Text]  
  • Andreozzi, F., Formoso, G., Prudente, S., Hribal, M. L., Pandolfi, A., Bellacchio, E., Di Silvestre, S., Trischitta, V., Consoli, A., Sesti, G. (2008). TRIB3 R84 Variant Is Associated With Impaired Insulin-Mediated Nitric Oxide Production in Human Endothelial Cells. Arterioscler. Thromb. Vasc. Bio. 28: 1355-1360 [Abstract] [Full Text]  
  • Rensing, K. L., Twickler, Th. B. (2008). Abdominal aorta aneurysm: an exceptional expression of atherosclerotic disease in type II diabetes. Eur Heart J 29: 581-582 [Full Text]  
  • Marini, M. A., Succurro, E., Frontoni, S., Hribal, M. L., Andreozzi, F., Lauro, R., Perticone, F., Sesti, G. (2007). Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women. Diabetes Care 30: 2145-2147 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»